EMA Application withdrawn: Imagify (perflubutane) — Acusphere Ltd

View source ↗

Summary

The EMA withdrew the application for Imagify (perflubutane) by Acusphere Ltd for ultrasonography use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ultrasonography-related Imaging Indication

Drugs mentioned

• Imagify (perflubutane)

Snippet

Status: Application withdrawn. Therapeutic area: Ultrasonography. MAH: Acusphere Ltd. Decision date: 28/08/2014